A股異動丨安居寶(300155.SZ)大跌近8% 收到深交所關注函
格隆匯11月12日丨安居寶(300155.SZ)今日大幅低開下跌,現大跌7.9%,報5.36元,暫成交6694萬元,最新總市值29億元。

安居寶昨日收盤收到深交所關注函,要求説明區塊鏈與主營業務的關係,目前區塊鏈業務收入和利潤規模佔比。此前,公司被認定為2019年第三批區塊鏈企業。昨日股價一度觸及漲停,盤中創階段新高,收漲3.56%。值得注意的是,目前安居寶有高管正在減持公司股份,目前尚處於減持期間內。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.